Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare Biotechnology

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > Exelon Drug bought by GUD.

<< Previous

Bullboard Posts

Next >>

Comment by Lookingforclueson Jun 26, 2021 10:59pm

91 Views

Post# 33456911

RE:RE:Exelon Drug bought by GUD.

Lookingforclues wrote:

Lookingforclues wrote: I was interested in this New Drug, but I would suggest that you read it's Capabilities.

Quote....It may not help with the Disease that it was developed for..
BUT 'It May and only May' assist with memory...

Then it advises that if you forget to take the Dosage for 3 or more days, you must inform your Dr who will start you on a lower dose!

These are the instruction on a Drug that may or many not work on your Memory........This is a quote from their Brief. Does one wonder here?!

Repost!